151 related articles for article (PubMed ID: 36870011)
1. Genetically Determined Levels of mTOR-Dependent Circulating Proteins and Risk of Multiple Sclerosis.
Zhang YC; Fan KY; Wang Q; Hu JX; Wang Q; Zhang HY; Song S; Zhao R; Qiao J; Zhang SX
Neurol Ther; 2023 Jun; 12(3):751-762. PubMed ID: 36870011
[TBL] [Abstract][Full Text] [Related]
2. Genetic Evidence Supporting Causal Roles of mTOR-Dependent Proteins in Rheumatic Fever: A Two-Sample Randomized Mendelian Study.
Mu YF; Wang Q; Hu JX; Wang Q; Zhang YC; Fan KY; Han ZY; Zhang HY; Cheng T; Zhao R; Song S; Qiao J; Zhang SX; Wang CH
Adv Ther; 2023 Apr; 40(4):1590-1600. PubMed ID: 36773079
[TBL] [Abstract][Full Text] [Related]
3. Causal Association Between mTOR-Dependent Protein Levels and Alzheimer's Disease: A Mendelian Randomization Study.
Cai HY; Hou SJ; Wen R; Feng QF; Xi YJ; Zhang SX; Qiao J; Wu MN
J Alzheimers Dis; 2023; 94(4):1477-1485. PubMed ID: 37393500
[TBL] [Abstract][Full Text] [Related]
4. Association of mTORC1‑dependent circulating protein levels with cataract formation: a mendelian randomization study.
Cai Y; Liu K; Wu P; Yuan R; He F; Zou J
BMC Genomics; 2022 Oct; 23(1):719. PubMed ID: 36271348
[TBL] [Abstract][Full Text] [Related]
5. Causal association between mTOR-dependent EIF-4E and EIF-4A circulating protein levels and type 2 diabetes: a Mendelian randomization study.
Soliman GA; Schooling CM
Sci Rep; 2020 Sep; 10(1):15737. PubMed ID: 32978410
[TBL] [Abstract][Full Text] [Related]
6. The causal effect of mTORC1-dependent circulating protein levels on nonalcoholic fatty liver disease: A Mendelian randomization study.
Yan X; Huang S; Li H; Feng Z; Kong J; Liu J
Dig Liver Dis; 2024 Apr; 56(4):559-564. PubMed ID: 37778897
[TBL] [Abstract][Full Text] [Related]
7. Coffee consumption is not associated with risk of multiple sclerosis: A Mendelian randomization study.
Lu H; Wu PF; Zhang W; Xia K
Mult Scler Relat Disord; 2020 Sep; 44():102300. PubMed ID: 32590313
[TBL] [Abstract][Full Text] [Related]
8. Growth Factors and Their Roles in Multiple Sclerosis Risk.
Lu H; Wu PF; Ma DL; Zhang W; Sun M
Front Immunol; 2021; 12():768682. PubMed ID: 34745143
[TBL] [Abstract][Full Text] [Related]
9. Genetic Evidence Supporting a Causal Association Between mTOR-Dependent EIF-4E Circulating Protein Level and Osteoporosis.
Cheng T; Zhang YC; Fan KY; Hu JX; Wang Q; Wang Q; Liu L; Zhang HY; Hou YP; Li XF; Zhang SX
Adv Ther; 2023 Nov; 40(11):4987-4998. PubMed ID: 37728694
[TBL] [Abstract][Full Text] [Related]
10. Causal association between mTOR-dependent circulating protein levels and central precocious puberty: a Mendelian randomization study.
Ying Y; Yu Z; Wu L
Front Endocrinol (Lausanne); 2024; 15():1360043. PubMed ID: 38516410
[TBL] [Abstract][Full Text] [Related]
11. Mendelian randomization study updates the effect of 25-hydroxyvitamin D levels on the risk of multiple sclerosis.
Wang R
J Transl Med; 2022 Jan; 20(1):3. PubMed ID: 34980161
[TBL] [Abstract][Full Text] [Related]
12. Genetically Determined Circulating Levels of Cytokines and the Risk of Rheumatoid Arthritis.
Qian Y; He Z; Zhao SS; Liu B; Chen Y; Sun X; Ye D; Jiang X; Zheng H; Wen C; Zheng H; Mao Y
Front Genet; 2022; 13():802464. PubMed ID: 35198006
[No Abstract] [Full Text] [Related]
13. Lung cancer risk in patients with multiple sclerosis: a Mendelian randomization analysis.
Ge F; Huo Z; Li C; Wang R; Wang R; Liu Y; Chen J; Lu Y; Wen Y; Jiang Y; Peng H; Wu X; Liang H; He J; Liang W
Mult Scler Relat Disord; 2021 Jun; 51():102927. PubMed ID: 33812221
[TBL] [Abstract][Full Text] [Related]
14. Associations of the circulating levels of cytokines with risk of amyotrophic lateral sclerosis: a Mendelian randomization study.
Liu B; Lyu L; Zhou W; Song J; Ye D; Mao Y; Chen GB; Sun X
BMC Med; 2023 Feb; 21(1):39. PubMed ID: 36737740
[TBL] [Abstract][Full Text] [Related]
15. Obesity and Multiple Sclerosis: A Mendelian Randomization Study.
Mokry LE; Ross S; Timpson NJ; Sawcer S; Davey Smith G; Richards JB
PLoS Med; 2016 Jun; 13(6):e1002053. PubMed ID: 27351487
[TBL] [Abstract][Full Text] [Related]
16. mTORC1-Dependent Protein and Parkinson's Disease: A Mendelian Randomization Study.
Tan C; Ai J; Zhu Y
Brain Sci; 2023 Mar; 13(4):. PubMed ID: 37190500
[TBL] [Abstract][Full Text] [Related]
17. Are neurodegenerative diseases associated with an increased risk of inflammatory bowel disease? A two-sample Mendelian randomization study.
Cui G; Li S; Ye H; Yang Y; Huang Q; Chu Y; Shi Z; Zhang X
Front Immunol; 2022; 13():956005. PubMed ID: 36159838
[TBL] [Abstract][Full Text] [Related]
18. Relationships between accelerometer-measured and multiple sclerosis: a 2-sample Mendelian randomization study.
Lu H; Wu PF; Li RZ; Zhang W; Huang GX
Neurol Sci; 2021 Aug; 42(8):3337-3341. PubMed ID: 33411191
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study.
Mokry LE; Ross S; Ahmad OS; Forgetta V; Smith GD; Goltzman D; Leong A; Greenwood CM; Thanassoulis G; Richards JB
PLoS Med; 2015 Aug; 12(8):e1001866. PubMed ID: 26305103
[TBL] [Abstract][Full Text] [Related]
20. Circulating Interleukins and Risk of Multiple Sclerosis: A Mendelian Randomization Study.
Lu H; Wu PF; Zhang W; Liao X
Front Immunol; 2021; 12():647588. PubMed ID: 33936066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]